NMG Lunchtime Seminar Series: Focus on Biomedical Materials

 

You are invited to join us for our monthly virtual event where the focus will be on Biomedical Materials

You will hear from

Prof. Ipsita Roy, The University of Sheffield

Medical Applications of Bacteria-derived Plastics - It's a Bug's Life!

• Ipsita Roy is a British-Indian materials scientist who is a professor at the University of Sheffield. Her research considers natural polymers of bacterial origin for medical applications. Her group is currently focused on the production of novel Polyhydroxyalkanoates (PHAs), a group of FDA-approved natural polymers and their characterisation.
• She has pioneered the production of PHAs from Gram positive bacteria which lack immunogenic properties and hence are excellent materials for medical applications. Her group is involved in the application of PHAs in the area of hard tissue engineering, soft tissue engineering, wound healing, drug delivery and medical device development.
• She has also initiated work with bacterial cellulose and γ-polyglutamic acid, as natural polymers for biomedical applications. PHAs are also environmentally friendly polymers that are biodegradable both in the soil and in the sea. She has recently initiated work related to this aspect of PHAs.

Dr Chris Holland, The University of Sheffield

The History of Silk in Medicine

• Dr Chris Holland is a Senior Lecturer in the School of Chemical, Materials and Biological  Engineering at the University of Sheffield. A biologist by degree and a materials scientist in practice, he received his training in the Oxford Silk Group, for the past 19 years his research into silk rheology has asked: “How is silk spun?”

• Today his group’s research uses tools developed for the physical sciences to better understand how processing affects performance in natural materials, with a focus on relating protein hydration to function (www.naturalmaterialsgroup.com).

Dr Ibolya Kepiro, National Physical Laboratories

Advances and need on metrology and standardisation for biomedical applications

• Ibolya Kepiro obtained her PhD from Imperial College London, where she studied in vivo high-resolution retinal imaging for clinical diagnostics. She was involved in several international projects leading the development of 3D structural imaging approaches combining light-sheet fluorescence microscopy with electrophysiology, drug delivery modelling in clinical administration and contributing to the design of nanotechnology strategies for the treatment of diabetic eye diseases.
• Ibolya joined NPL in 2017. Her current research focuses on applying high-resolution and correlative imaging (including light- and electron microscopy with chemical imaging) and characterization of self-assembly model systems to support and promote the advancement of synthetic biology at the high metrology order. 

Preliminary agenda

13:00 – Start and greetings
13:05 – Presentations
14:00 – General discussion
14.30 – Close